Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
CIBC Atlas Equity Income Institutional AWYIX
- NAV / 1-Day Return 57.05 / +0.30 %
- Total Assets 317.6 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.900%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Large Blend
- Investment Style Large Blend
- Min. Initial Investment 250,000
- Status Open
- TTM Yield 1.62%
- Turnover 27%
USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 10:12 PM GMT+0
Morningstar’s Analysis AWYIX
Will AWYIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 42.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Microsoft Corp | 5.39 | 15.0 Mil | Technology |
Enterprise Products Partners LP | 5.09 | 14.2 Mil | Energy |
Eli Lilly and Co | 4.90 | 13.6 Mil | Healthcare |
First American Government Obligs X | 4.21 | 11.7 Mil | Cash and Equivalents |
Elevance Health Inc | 4.16 | 11.6 Mil | Healthcare |
Apple Inc | 4.06 | 11.3 Mil | Technology |
AstraZeneca PLC ADR | 4.05 | 11.3 Mil | Healthcare |
Blackstone Inc | 3.74 | 10.4 Mil | Financial Services |
Abbott Laboratories | 3.68 | 10.2 Mil | Healthcare |
CME Group Inc Class A | 3.46 | 9.6 Mil | Financial Services |